Medicare Advantage, value-based care, senior health, and healthcare ethics—Dr. Sachin Jain and Roy Bejarano unpack what sustainable healthcare reform should actually look like.

In this episode of Analyzing Healthcare, Roy Bejarano speaks with Dr. Sachin Jain, CEO of SCAN Health Plan, the largest not-for-profit Medicare Advantage health plan in the U.S. They explore the current state of Medicare Advantage, what separates strong plans from weak ones, and why healthcare leadership must return to ethics, prevention, and long-term value creation.

Sachin explains how SCAN scaled to roughly 440,000 members, why star ratings matter so much, and how delegated risk models can create better alignment between plans and providers. He also shares lessons from operating across payer and care delivery models, why vertical integration is harder than many assume, and how the future of senior care must move beyond paying for sickness toward keeping people healthy.

What You’ll Learn

 ✅ What most leaders misunderstand about Medicare Advantage

✅ The difference between “good” and “bad” MA models

✅ How risk adjustment and coding incentives distorted the market

✅ Why V28 exposed weaker MA operators

✅ How SCAN uses delegated risk and provider partnerships

✅ Why star ratings are critical for growth and economics

✅ Why building care delivery platforms is operationally difficult

✅ How ethics and incentives shape healthcare performance

✅ Why senior care must shift toward prevention and outcomes

Key Timestamps

(00:00) Introduction to Medicare Advantage and SCAN Health Plan

(02:38) Challenges in Care Delivery and Scaling Services

(05:31) Understanding Medicare Advantage: Good vs. Bad Plans

(08:27) Federal Changes and Their Impact on Medicare Advantage

(10:49) The Ethical Landscape of Healthcare

(13:47) Growth and Expansion of SCAN Health Plan

(16:26) Partnerships and Provider Relationships

(18:59) Navigating the Medicare Advantage Market

(21:41) Future of Senior Care and Healthcare System

(24:35) Lessons from Previous Experiences in Healthcare

(27:11) Conclusion and Future Outlook

Key Takeaways

 💎 Strong Medicare Advantage plans improve care coordination and outcomes

💎 Weak MA models rely too heavily on coding and short-term incentives

💎 SCAN’s growth has been driven by discipline, trust, and star performance

💎 Delegated risk works best when providers are aligned around outcomes

💎 Vertical integration is strategically valuable but hard to execute

💎 Healthcare needs stronger ethical leadership and better incentives

💎 The future of senior care is prevention, not reactive reimbursement

Guest Bio

Dr. Sachin H. Jain, MD, MBA, is CEO of SCAN Group and SCAN Health Plan, where he leads growth, diversification, and healthcare equity efforts. Under his leadership, SCAN has expanded into new markets, launched innovative health plan products, and earned leading quality and customer satisfaction ratings. Previously, he led CareMore Health and Aspire Health and held leadership roles at Merck and HHS. Dr. Jain is a physician, policy expert, board member, and nationally recognized thought leader in healthcare.

SEO Keywords

Healthcare, Medicare Advantage, Value-Based Care, Senior Care, SCAN Health Plan, Sachin Jain, Roy Bejarano, Scale Community, Healthcare Leadership, Risk Adjustment, V28, Delegated Risk, Star Ratings, Preventive Care, Population Health, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

Orthopedic MSO strategy, hospital partnerships, physician independence, AI in healthcare, and Rothman Orthopaedics growth. In this episode of Analyzing Healthcare, Jason Schifman speaks with Christian Ellison, CEO of Rothman Orthopaedics, about building one of the nation’s leading doctor-owned orthopedic platforms. They discuss physician independence, hospital partnerships, ambulatory growth, patient access, AI-enabled care delivery, and why focused specialty platforms may outperform traditional employed models. Christian also shares Rothman’s approach to market expansion, recruiting, and scaling orthopedic care without losing strategic focus.

What You’ll Learn
✅ Why independent physician groups may outperform employed models
✅ How Rothman partners with hospitals across Pennsylvania, New Jersey, and Florida
✅ What “demand matching” means in orthopedic care delivery
✅ How nurse navigation reduces friction and keeps patients out of the ER
✅ Why AI should move beyond efficiency into care redesign
✅ How Rothman scaled from 0% to 30% market share in Orlando in 3 years
✅ Why physician training pipelines matter for growth
✅ The role of brand in recruiting doctors across markets
✅ What specialties are most likely to move from acute care to ambulatory settings
✅ Why focus — not over-expansion — creates real value in specialty care

Key Timestamps
• (01:06) Rothman’s footprint and doctor-owned model
• (02:45) How Rothman structures hospital partnerships
• (07:13) Why integrated care is better for patients
• (12:21) “Demand matching” and nurse navigation
• (13:37) AI and the future of care delivery
• (15:23) Why hospitals are more open to partnership now
• (18:43) Independent groups vs. employed physician economics
• (29:43) Florida expansion and 30% market share growth
• (36:12) Rothman’s 3–5 year growth strategy
• (46:41) “The reason we’re so good is because all we do is orthopedics.

Key Takeaways
• 💎 Organizations must focus on delivering specialized care to achieve excellence.
• 💎 Comprehensiveness in care is challenging for hospital systems with multiple specialties.
• 💎 Emerging organizations like Rothman Orthopedics are setting new standards in specialized care.
• 💎 Collaboration between specialized organizations can create significant market value.
• 💎 Quality care requires sophisticated systems and processes.
• 💎 The healthcare market is evolving with a focus on specialized services.
• 💎 Delivering the best care involves custom components tailored to specific needs.
• 💎 Healthcare providers face challenges in maintaining excellence across various specialties.
• 💎 The emergence of specialized organizations can lead to improved patient outcomes.
• 💎 A focused approach in healthcare can drive innovation and efficiency.

Resource Links
Guest: Christian Ellison – CEO, Rothman Orthopaedics
Host: Jason Schifman – President & Co-Founder, SCALE Healthcare
Podcast: Analyzing Healthcare by SCALE Community
SCALE Community: https://www.scale-community.com
SCALE Healthcare: https://www.scale-healthcare.com
Rothman Orthopaedics: https://rothmanortho.com

Guest Bio-
Christian Ellison is CEO of Rothman Orthopaedics, the largest private musculoskeletal practice in the U.S. With more than 30 years of healthcare leadership experience, he is known for driving strategic growth, operational excellence, and multi-market expansion across physician-led organizations. His expertise includes scaling outpatient care delivery models, strengthening performance across complex healthcare platforms, and leading specialty care organizations through transformation. Prior to Rothman, he served as CEO and Board Member at EVP EyeCare, an investor-backed ophthalmic care organization.

SEO Keywords
Rothman Orthopaedics, Christian Ellison, Jason Schifman, SCALE Healthcare, Analyzing Healthcare, orthopedic MSO, hospital partnerships, physician independence, value-based care, ambulatory surgery centers, orthopedic strategy

Health system mergers, safety-net sustainability, AI in healthcare, and FTC scrutiny—Dixie James and Roy Bejarano unpack what responsible scale really means.In this episode of Analyzing Healthcare, Roy Bejarano speaks with Dixie James,Regional President at Jefferson Health, about the realities of integrating health systems without losing mission or community trust.

Drawing on her leadership through the Einstein Healthcare Network merger—including FTC opposition and COVID—Dixie explains why safety-net hospitals cannot survive without scale and capital access. She shares lessons from integration, AI investment, health plan performance, and why culture—not capital—is the hardest part of any merger.

A candid discussion on regulation, regional strategy, and the human side of healthcare consolidation.

What You’ll Learn

✅ Why safety-net hospitals are unsustainable without scale and capital access
✅ What the FTC often misunderstands about hospital mergers
✅ How regional scale improves coordinated care across the continuum
✅ Why integration success depends more on people than process
✅ Lessons learned from Einstein → Jefferson vs. Lehigh Valley integration
✅ How large systems pilot AI, automation, and virtual nursing at scale
✅ The strategic role of Jefferson’s health plan in population health
✅ Why GLP-1 exposure disrupted payer economics in 2025
✅ How regional concentration enables true “soup-to-nuts” care
✅ Why change management can make or break a merger

Key Timestamps

• (00:00) Introduction to Dixie James and Jefferson’s scale
• (03:24) The five-year merger journey: FTC challenge, AG opposition, and COVID
• (06:20) Safety-net payer mix (85–90% government) and sustainability reality
• (08:52) What Einstein’s culture brought to Jefferson
• (13:26) If she could go back to 2015: technology investments and AI readiness
• (14:35) Jefferson’s AI Center of Excellence and research infrastructure
• (16:46) Observing other mergers: monopoly fears vs. mission-driven scale
• (21:15) Coordinated vs. uncoordinated care—regional advantages
• (23:36) Jefferson Health Plan performance and GLP-1 impact
• (26:46) Lessons learned: Einstein integration vs. Lehigh Valley
• (31:33) The hardest part of integration—“moving people’s cheese”

Key Takeaways

• 💎 Scale isn’t about monopoly—it’s about sustainability for safety-net care
• 💎 85–90% government payer mix is financially unsustainable without capital access
• 💎 Regional density enables coordinated, continuous care—not episodic treatment
• 💎 AI investment requires infrastructure smaller systems can’t afford
• 💎 Integration fails when teams don’t understand the “why”
• 💎 Culture transfer from small systems can strengthen large enterprises
• 💎 Health plans must align strategically with system population health goals
• 💎 Change management—not finance—is the hardest integration challenge

Resource Links

Guest: Dixie James – Regional President, Jefferson Health
Host: Roy Bejarano – CEO & Co-Founder, SCALE Healthcare
Podcast: Analyzing Healthcare by SCALE Community
SCALE Community: https://www.scale-community.com

Guest Bio

Dixie Anne James is Regional President of Jefferson Hospital, overseeing a multi-hospital academic and community network across Pennsylvania and New Jersey. With more than 25 years in healthcare leadership, she previously served as President and CEO of Einstein Medical Center Philadelphia and played a key role in the merger of Einstein Healthcare Network with Jefferson. Her expertise spans safety-net sustainability, large-scale integration, service line growth, and advancing coordinated, technology-enabled care.

SEO Keywords

Healthcare, Mergers, Technology, Community Care, Leadership, Jefferson Health, Einstein Health, Regulatory Challenges, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

Jorge Juan Fernandez discusses public healthcare innovation, hospital spinouts, CAR-T therapies, and why collaboration is shaping modern care delivery. In this episode of Analyzing Healthcare, he joins Jason Schifman to share how Hospital Clínic Barcelona became one of Europe’s most dynamic innovation engines.Fernandez explains how a public healthcare system can launch venture-backed startups, develop CAR-T therapies, and embed innovation across 9,000 employees. The discussion covers commercialization, operational ROI, cultural transformation, primary care integration, and hospital alliances that expand access and reduce inefficiencies. He emphasizes that innovation must improve operations—and that no single hospital can deliver world-class care alone.

What You’ll Learn

• ✅ How a public hospital created 30+ spinout companies across biotech, medtech, and digital health
• ✅ The three-part innovation model: In-Out, In-In, and Out-In
• ✅ Why operational improvement—not hype—is the test for adopting new technology
• ✅ How frontline clinicians and nurses drive meaningful innovation
• ✅ Why public systems can compete with pharma through structured tech transfer
• ✅ How CAR-T therapies moved from research to national deployment
• ✅ Why strategic partnerships are essential for modern healthcare delivery

Key Timestamps

• (00:43) Introduction to Hospital Clínic Barcelona and its global positioning
• (09:43) Defining innovation in a public hospital system
• (10:06) 30+ spinouts: competing with pharma and building companies
• (15:35) Building a culture of innovation across 9,000 employees
• (20:10) Internal innovation awards and frontline problem-solving
• (26:56) Operational ROI: why great startups still fail in hospitals
• (33:00) Strategic partnerships with primary care and rural hospitals
• (36:40) “One hospital is not enough” — collaboration as strategy

Key Takeaways

• 💎 Public healthcare systems can innovate at scale with structured pathways
• 💎 Commercial success begins with research strength and tech transfer discipline
• 💎 Innovation must materially improve operations to earn adoption
• 💎 Frontline pain points—not executive mandates—drive sustainable change
• 💎 Strategic alliances expand access without duplicating infrastructure
• 💎 Collaboration across care settings is a competitive advantage

Guest

Jorge Juan Fernandez Garcia
Chief Innovation Officer at Hospital Clínic Barcelona

Guest Bio

Jorge Juan Fernandez Garcia is Chief Innovation Officer at Hospital Clínic Barcelona, leading innovation strategy across four institutions within Campus Clínic Barcelona, including research foundations and global health initiatives. Under his leadership, the organization has launched more than 30 spinout companies across biotech, medtech, and digital health. Hospital Clínic is a top-ranked public tertiary hospital and a European leader in CAR-T therapy development, competing directly with pharmaceutical manufacturers in advanced therapies and translational research.

Subscribe

Subscribe to Analyzing Healthcare for candid conversations with healthcare leaders, clinicians, and system builders exploring healthcare strategy, AI in healthcare, digital health, and the future of care delivery.

Visit Scale Community- www.scale-commmunity.com to access exclusive healthcare insights, member-only recordings, and leadership perspectives from across the global healthcare ecosystem.

Keywords

public healthcare innovation, Hospital Clínic Barcelona, Jorge Fernandez, healthcare innovation, CAR-T therapy, biotech startups, hospital spinouts, digital health, healthcare commercialization, healthcare strategy, public-private partnerships, healthcare cost efficiency, hospital alliances, primary care integration, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

Physician burnout, AI in healthcare, and private equity—Kevin Pho and Roy Bejarano explore the future of U.S. medicine and its challenges. In this episode of Analyzing Healthcare, host Roy Bejarano sits down with Kevin Pho, MD, founder of KevinMD, to examine what’s driving physician burnout—and what might actually help fix U.S. healthcare.

Drawing on two decades as a practicing physician and leading voice in healthcare media, Kevin unpacks the loss of autonomy, growing corporatization, reimbursement pressure, and productivity metrics pushing clinicians toward burnout. He explains why burnout is a slow-burn crisis, how online platforms have replaced the physician lounge, and why isolation is worsening across specialties.

The conversation also explores AI’s role in healthcare, separating tools that reduce cognitive load from those that introduce new clinical and ethical risks, alongside a candid discussion on private equity, regulation, and patient outcomes.

What You’ll Learn

• Why physician burnout is worsening—even as healthcare spending rises.

• How loss of autonomy and corporatization are reshaping medical practice.

• Why productivity metrics and reimbursement pressures fuel moral injury.

• How KevinMD became a modern “physician lounge” for shared experience.

• Where AI genuinely helps clinicians—and where it creates new risks.

• Why ambient AI scribes may reduce burnout but raise privacy questions.

• How Silicon Valley’s pace clashes with patient safety realities.

• The unresolved debate around private equity and patient outcomes.

• Why training more physicians alone won’t fix access or burnout.

• What healthcare leaders must prioritize over the next decade.

Key Timestamps

(00:00) Kevin Pho’s journey from primary care physician to KevinMD
(04:25) Burnout, moral injury, and why physicians feel isolated
(07:45) Loss of autonomy and the corporatization of medicine
(10:10) Are physicians burning out faster—or just steadily worse?
(13:40) Metrics vs. medicine: where the system breaks
(17:15) Private equity in healthcare—risk, reality, and regulation
(24:35) AI in healthcare: real tools vs. dangerous hype
(26:40) Why AI won’t replace doctors—but may replace those who ignore it
(29:20) “Move fast and break things” vs patient safety
(33:30) Residency caps, physician shortages, and structural bottlenecks

Key Takeaways

• Burnout is a systemic failure, not an individual weakness.

• Loss of physician autonomy is a primary driver of moral injury.

• Metrics without clinical context worsen care and clinician wellbeing.

• AI can reduce cognitive load—but also introduce serious safety risks.

• Healthcare cannot adopt Silicon Valley’s speed without consequences.

• Private equity’s impact on care is nuanced—not binary.

• Training more doctors won’t solve access without structural reform.

Resource Links

Guest: Kevin Pho, MD – Founder, KevinMD
Host: Roy Bejarano – CEO & Co-Founder, SCALE Healthcare
Podcast: Analyzing Healthcare
SCALE Community: https://www.scale-community.com

Guest Bio

Dr. Kevin Pho is a board-certified internal medicine physician and the founder of KevinMD, the leading physician-led media platform amplifying frontline clinical voices. Since launching KevinMD in 2004, he has built a global community where clinicians share real-world experiences on burnout, autonomy, health policy, and emerging technologies like AI. Dr. Pho brings a practicing physician’s perspective to national healthcare debates and continues to care for patients in New Hampshire.

SEO Keywords

Physician burnout, Kevin Pho, KevinMD, AI in healthcare, healthcare innovation, private equity in healthcare, physician autonomy, healthcare policy, healthcare AI, medical burnout, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Roy Bejarano, Jason Schifman

Bob Wachter on AI in healthcare, EMRs, digital health, clinician burnout, and why generative AI may succeed where healthcare technology failed. In this episode of Analyzing Healthcare, Jason Schifman speaks with Bob Wachter, Chair of Medicine at UCSF and author of A Giant Leap, on why AI may finally transform healthcare.

Wachter explains how EMRs increased administrative burden without delivering productivity gains, and why generative AI marks a shift by making clinical data and decision-making computable. The conversation covers real-world AI adoption—scribes, chart summarization, and decision support—while examining ROI, clinical risk, and human oversight. Wachter emphasizes that AI won’t fix healthcare’s incentives, but it can meaningfully improve clinician experience and care delivery.

What You’ll Learn

• Why EMRs digitized healthcare without transforming it

• What makes generative AI fundamentally different from prior health IT waves

• Where AI delivers real value today—and where it still falls short

• Why clinician experience may be AI’s strongest early ROI

• How AI could reshape diagnosis, testing, and treatment decisions

• The risks of human–AI collaboration in clinical care

• Why AI can improve healthcare without replacing doctors

Key Timestamps

• (00:00) Introduction to Bob Wachter and AI in healthcare

• (04:13) Why EMRs failed to transform healthcare delivery

• (09:37) General-purpose technology and healthcare digitization

• (15:42) Why AI adoption is happening “suddenly,” not gradually

• (19:38) What makes generative AI different from past tools

• (34:03) AI scribes: adoption, experience, and ROI reality

• (38:15) Clinical decision support as AI’s true “home run”

• (44:16) Unintended consequences and the human-in-the-loop risk

Key Takeaways

• 💎 Digitization alone does not equal transformation

• 💎 Generative AI enables healthcare data to become computable

• 💎 Clinician experience is a critical early driver of AI adoption

• 💎 Real cost savings depend on changing clinical decisions, not documentation

• 💎 AI can improve healthcare without fixing broken incentives

• 💎 Human oversight introduces new risks alongside new benefits

Guest

Bob Wachter, MD
Chair, Department of Medicine, UCSF
Author, A Giant Leap: How AI Is Transforming Healthcare and What It Means for Our Future

Guest Bio

Bob Wachter, MD, is Professor and Chair of the Department of Medicine at the University of California, San Francisco, and a nationally recognized leader in healthcare quality, safety, and innovation. He coined the term “hospitalist,” the fastest-growing medical specialty in U.S. history, and has authored six books and hundreds of articles on health technology and policy. His 2015 book The Digital Doctor was a New York Times bestseller, and his latest, A Giant Leap, explores AI’s impact on care.

Subscribe

Subscribe to Analyzing Healthcare for candid conversations with healthcare leaders, clinicians, and system builders exploring healthcare strategy, AI in healthcare, digital health, and the future of care delivery.

Visit Scale Community- www.scale-commmunity.com to access exclusive healthcare insights, member-only recordings, and leadership perspectives from across the global healthcare ecosystem.

Keywords

AI in healthcare, Bob Wachter, healthcare innovation, electronic health records, EMR adoption, digital health, clinical decision support, physician, healthcare productivity, healthcare costs, healthcare technology, affordable healthcare, healthcare solutions, healthcare access, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

Healthcare innovation doesn’t fail because of a lack of science—it fails when governance, execution, and incentives break down. In this episode of Analyzing Healthcare, host Roy Bejarano, CEO & Co-Founder of SCALE Healthcare, sits down with George Syrmalis, Founder & CEO of Bioscience Equity Partners, to unpack how early-stage biotech, medtech, and digital health investments are really evaluated—and why most countries fail to attract global capital.

Drawing on decades of experience as a physician, biotech founder, and global investor, George explains why governance, intellectual property, execution quality, and regulatory clarity matter more than geography. The conversation explores early-stage biotech funding, global clinical trial strategy, FDA vs international regulators, Big Pharma’s looming patent cliff, radiopharmaceuticals, AI in drug discovery, and why “innovation without impact” doesn’t get funded.

From why the U.S. remains the most attractive biotech market to how Saudi Arabia is rapidly emerging as a future life sciences hub, this episode delivers a rare, operator-level view into how capital actually flows across global healthcare innovation.

What You’ll Learn

✅ How global biotech investors assess early-stage risk and return
✅ Why governance and IP matter more than geography
✅ How FDA clarity often outweighs lower clinical trial costs abroad
✅ Why many countries struggle to attract life sciences capital
✅ The real bottlenecks in clinical trials and contract manufacturing
✅ How Big Pharma’s patent cliff will reshape M&A and deal flow
✅ Where radiopharmaceuticals, medtech, and AI are creating real value
✅ Why most “AI in healthcare” pitches don’t survive diligence

Key Timestamps

• (00:00) George Syrmalis’ background and investment philosophy
• (05:10) Governance, IP, and biotech deal breakers
• (10:20) Why the U.S. dominates global biotech investing
• (12:15) Where to run clinical trials—and where not to
• (18:20) FDA clarity vs lower-cost regulators
• (22:35) Big Pharma’s patent cliff and M&A surge
• (25:30) Where capital is moving in biotech and medtech
• (29:40) Real AI vs hype in healthcare• (32:00) Tariffs, pricing risk, and capital strategy

Key Takeaways

• 💎 Early-stage biotech success depends on execution, governance, and IP
• 💎 FDA transparency often outweighs lower global trial costs
• 💎 Clinical trial quality matters more than geography
• 💎 Manufacturing failures can derail approvals and destroy value
• 💎 Big Pharma’s patent cliff will drive aggressive M&A
• 💎 Radiopharmaceuticals and medtech are entering a second growth wave
• 💎 Most healthcare AI pitches fail real diligence

Resource Links

Guest: George Syrmalis – Founder & CEO, Bioscience Equity Partners
Host: Roy Bejarano – Analyzing Healthcare
Community: www.scale-community.com
Podcast Hub: Analyzing Healthcare by SCALE Community

Guest Bio

Dr. George Syrmalis is a physician-scientist, entrepreneur, and global healthcare investor best known as Founder & CEO of Bioscience Equity Partners, a specialist investment bank and fund manager focused on early-stage biotech, med-tech, and digital health ventures. He has decades of experience bridging scientific innovation and capital markets, helping groundbreaking life sciences technologies advance from discovery through financing and public markets. His leadership emphasizes rigorous science, governance, and strategic execution to accelerate meaningful healthcare innovations worldwide.

SEO Keywords

Biotech, healthcare investment, clinical trials, AI in healthcare, Dr. George Syrmalis, investment strategies, global healthcare, pharmaceutical industry, innovation in medicine, biotech trends, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Roy Bejarano, Scale Community, Jason Schifman

Healthcare innovation continues to accelerate, yet access, affordability, and patient experience remain persistent challenges across the U.S. healthcare system. Despite advances in digital health and healthcare technology, many solutions fail to address the root issues driving cost, complexity, and fragmented care delivery.

In this episode of Analyzing Healthcare, host Jason Schifman sits down with Glen Tullman, CEO of Transcarent, to examine why healthcare systems struggle to deliver affordable healthcare and consistent access—and what healthcare strategies can actually move the industry forward. Glen shares how Transcarent is rethinking digital health by prioritizing patient experience, decision support, and AI in healthcare to simplify access to care for employees and their families.

The conversation explores how healthcare solutions must align incentives, technology, and experience to improve outcomes. Glen also reflects on broader healthcare trends and innovations, explaining why leading healthcare stakeholders must focus less on volume-driven care and more on scalable, consumer-centered healthcare innovations that improve access, quality, and cost simultaneously.

What You’ll Learn

✅ Why healthcare innovation has not translated into better patient experience
✅ How AI in healthcare can improve access and guide better care decisions
✅ What digital health platforms must get right to drive adoption and impact
✅ Why affordable healthcare depends on fixing incentives, not adding complexity
✅ How healthcare technology can simplify navigation across fragmented systems
✅ What leading healthcare stakeholders should prioritize in today’s market

Subscribe

Subscribe to Analyzing Healthcare for in-depth conversations with thought leaders in healthcare covering healthcare strategy, healthcare technology, and the latest trends in healthcare.

Visit Scale Community to access exclusive healthcare industry insights, member-only recordings, and leadership perspectives from across the healthcare ecosystem.

Timestamps

• (00:00) Why healthcare innovation hasn’t fixed access or affordability
• (03:05) Glen Tullman’s perspective on healthcare trends and innovation cycles
• (07:10) Why patient experience remains the biggest failure point
• (10:20) Volume-driven incentives and unnecessary care
• (14:50) Digital health lessons from EMRs and healthcare technology
• (18:35) AI in healthcare and simplifying decision-making
• (22:10) Creating a single front door to healthcare access
• (26:15) Employers, digital health, and healthcare strategy alignment
• (31:45) Affordable healthcare through better system design
• (36:10) What the future of healthcare innovation requires

Key Takeaways

• 💎 Healthcare innovation must focus on experience to drive adoption
• 💎 AI in healthcare is most powerful when applied to navigation and decisions
• 💎 Digital health solutions must reduce complexity, not add layers
• 💎 Affordable healthcare requires fewer unnecessary interventions
• 💎 Healthcare strategy succeeds when incentives align with outcomes

Guest

Glen Tullman, CEO, Transcarent
Host: Jason Schifman, President & Co-Founder, SCALE Healthcare

Organization: https://www.scale-community.com
Podcast Hub: Analyzing Healthcare by SCALE Community

Guest Bio

Glen Tullman is CEO of Transcarent, where he is working to simplify healthcare by giving employees of self-insured employers a single, consumer-directed front door to high-quality, affordable care. Previously, Glenn founded Livongo, leading its historic IPO and $18.5B merger with Teladoc, and earlier served as CEO of Allscripts. Across his career, he has focused on aligning incentives, improving experience, and reducing unnecessary cost in healthcare.

Keywords

Healthcare innovation, Glen Tullman, Transcarent, digital health, patient experience, AI in healthcare, healthcare technology, affordable healthcare, healthcare solutions, healthcare access, Healthcare Podcast

Healthcare costs keep rising because trade-offs are unavoidable. Dr. Aaron Carroll explains pricing, policy, insurance limits, and global healthcare systems.

In this episode of Analyzing Healthcare, host Roy Bejarano, CEO & Co-Founder of SCALE Healthcare, sits down with Dr. Aaron E. Carroll, President & CEO of AcademyHealth, to unpack why U.S. healthcare remains the most expensive system in the world—and why no reform comes without painful trade-offs.

Drawing on decades of health services research and policy leadership, Dr. Carroll explains why rising premiums, shrinking coverage, and public frustration are driven less by insurance design and more by pricing, delivery models, and political reluctance to confront trade-offs. The conversation explores healthcare costs, insurance, public health investment, innovation incentives, global healthcare systems, and lessons from countries like Switzerland, Singapore, Canada, and the UK.

What You’ll Learn

✅ Why healthcare costs in the U.S. remain structurally high
✅ How trade-offs shape healthcare policy decisions
✅ Why insurance is not the core driver of healthcare inflation
✅ The role of public health and prevention in long-term outcomes
✅ What global healthcare systems get right—and wrong
✅ Why innovation thrives in U.S. healthcare despite inefficiencies
✅ How political avoidance worsens healthcare challenges

Timestamps

• (00:00) Introduction: Academy Health and healthcare policy
• (02:54) Why healthcare costs keep rising
• (09:03) “Everything is to blame” in U.S. healthcare spending
• (18:41) The real difference between U.S. and global healthcare systems
• (29:38) Why single-payer won’t fix healthcare costs
• (31:40) Innovation, incentives, and trade-offs
• (39:45) Public vs private responsibility in healthcare delivery
• (44:44) Why insurance debates miss the real problem

Key Takeaways

• 💎 Healthcare trade-offs are unavoidable—there are no cost-free solutions
• 💎 High healthcare costs are driven by pricing and delivery, not insurance alone
• 💎 Public health and prevention improve outcomes, even if they don’t always cut costs
• 💎 Global healthcare systems balance public and private roles more explicitly
• 💎 Innovation in healthcare is fueled by incentives—but comes with complexity

Resource Links

Guest: Dr. Aaron E. Carroll – President & CEO, AcademyHealth
Host: Roy Bejarano – Analyzing Healthcare
Community: www.scale-community.com
Podcast Hub: Analyzing Healthcare by SCALE Community

Guest Bio

Dr. Aaron E. Carroll is President & CEO of AcademyHealth and a nationally recognized physician, health policy researcher, and thought leader in healthcare economics. A former academic leader at Indiana University, he has spent decades advancing evidence-based healthcare policy, health services research, and public health reform. Dr. Carroll is widely known for translating complex healthcare systems, insurance dynamics, and global health trade-offs into clear, data-driven insights that inform policymakers, executives, and healthcare leaders.

SEO Keywords

Academy Health, healthcare costs, healthcare innovation, healthcare policy, insurance, public health, healthcare systems, trade-offs, healthcare challenges, global health, AI in Healthcare, Managed Care, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

Pediatric care in the U.S. is increasingly defined by fragmentation — especially for children with complex needs and those covered by Medicaid and CHIP. Access barriers, disconnected services, and lack of coordination often leave families navigating care on their own, with real consequences for outcomes.

In this episode of Analyzing Healthcare, host Jason Schifman speaks with Chris Johnson of Bluebird Kids Health about what actually drives pediatric outcomes and why traditional, encounter-based models fall short. Chris explains why most determinants of pediatric health exist outside the clinic, how integrating physical health, behavioral health, and social care is essential to improving outcomes, and why children play a central — but often misunderstood — role in Medicaid performance.

The conversation focuses on practical system design: aligning care teams, coordinating across community resources, and redefining success around impact — measured in healthier days at home, not just utilization.

What You’ll Learn

✅ How digital care platforms are improving access, efficiency, and outcomes
✅ Why data integration and interoperability remain foundational challenges
✅ How healthcare organizations can scale innovation without disrupting care delivery
✅ The role of partnerships in accelerating healthcare transformation
✅ What healthcare leaders must prioritize when adopting new technology
✅ How patient-centric design drives adoption and long-term impact

Subscribe

Subscribe to Analyzing Healthcare for in-depth conversations with leaders transforming healthcare through strategy, technology, policy, and global innovation.

Visit SCALE Community to access exclusive leadership insights and full member-only recordings.

Timestamps

• (00:00) Why pediatric care is broken in the U.S.
• (03:12) The scale and complexity of caring for high-need children
• (07:45) Where fragmentation hurts families and outcomes most
• (12:30) How Bluebird Kids Health integrates care beyond the clinic
• (17:10) Aligning clinical teams, data, and family support
• (21:55) Technology’s role in coordinating pediatric care
• (26:40) Working with payers and health systems in the U.S.
• (31:20) Measuring outcomes in pediatric population health
• (36:05) What scalable pediatric care models must get right
• (40:30) Lessons for U.S. healthcare leaders and policymakers

Key Takeaways

• 💎 Digital platforms are becoming central to modern care delivery
• 💎 Interoperability is essential for scaling value-based models
• 💎 Technology must align with clinical workflows to drive adoption
• 💎 Partnerships accelerate innovation across fragmented systems
• 💎 Patient-centric design is critical to long-term success

Guest: Chris Johnson, Founder & CEO Bluebird Kids Health
Host: Jason Schifman, President & Co-Founder, SCALE Healthcare

Organization: https://www.scale-community.com
Podcast Hub: Analyzing Healthcare by SCALE Community

Guest Bio

Chris Johnson is a healthcare executive and innovator focused on advancing pediatric care through technology-enabled, family-centered models. As a leader at Bluebird Kids Health, Chris works at the intersection of clinical care, digital health, and care coordination to improve access and outcomes for children with complex and chronic needs. His work centers on building scalable pediatric care platforms that integrate primary care, specialty services, and social support—reducing fragmentation while supporting families beyond traditional clinical settings. Chris brings a practical, systems-level perspective on how pediatric healthcare can evolve to deliver higher-quality, more equitable care at scale.

Keywords

Digital healthcare, care delivery platforms, healthcare technology, interoperability, data-driven healthcare, population health, value-based care, healthcare challenges, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman